Definitive Contract 75N91020C00017
Award Date
9/15/20
Potential Completion Date
9/15/21
Potential Value
$400K
Federal Agency
National Cancer Institute
Awardee
Melax Technologies Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Houston, TX 77030, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
15
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $399,870 firm-fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Apricity Health LLC, a small business based in Houston, Texas. The contract is for the development of "Cancer Clinical Trials Recruitment and Retention Tools for Participant Engagement" under a total small business set-aside solicitation. The original solicitation, PHS-2020-1, sought proposals from small businesses for SBIR...
This is a $599,998.00 firm fixed price contract awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Melax Technologies Inc., a for-profit small business. The contract was awarded under the Small Business Innovation Research (SBIR) program, which does not have a set-aside designation, to conduct research and development of advanced data analytics technologies focused on healthcare applications. The work is being performed in Houston,...
This definitive contract was awarded by the National Institutes of Health National Cancer Institute to Massive Bio, Inc. for $399,594. The contract is associated with the National Institutes of Health and Centers for Disease Control and Prevention SBIR Phase I solicitation seeking proposals for research and development in support of cancer-related topics including clinical trials recruitment and retention tools for participant engagement. The contract will be performed in New York, New York from...
This $399,987 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Cancer Institute (NCI), a part of the National Institutes of Health (NIH), to Care Progress LLC, a small business limited liability company. The contract supports the development of cancer clinical trials recruitment and retention tools for participant engagement, as described in the original SBIR solicitation. The solicitation sought proposals for SBIR Phase I and Phase II contracts to conduct...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Pieces Technologies Inc., a small business, under the Small Business Innovation Research (SBIR) Phase II program. The contract, worth $1,999,994.00, is for the project titled "Passive and Active AI Screening for Social Determinants of Health and Interventions to Improve Outcomes in the Cancer Patient Population." The contract has a period of performance from September 16,...
This contract award, valued at $2,000,000.00, was made by the National Cancer Institute (NCI) to Mednet, Inc. for the 2024 SBIR TOPIC 465 program focused on "CANCER PREVENTION AND TREATMENT CLINICAL TRIALS TOOLS FOR RECRUITMENT AND RETENTION OF DIVERSE POPULATIONS". The contract is a Definitive Contract with a Firm Fixed Price pricing type and has a set-aside designation for Total Small Business. The work will be performed in New York, NY 10010 and is scheduled for completion by...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
This federal contract award, valued at $400,000.00, was issued by the National Cancer Institute (NCI) to Elate Medical, Inc., a small business located in Houston, Texas. The contract is for the Small Business Innovation Research (SBIR) Phase I effort under Topic 445 - "Advanced Manufacturing to Speed Availability of Emerging Autologous Cell-based Therapies". The ultimate completion date for this Firm Fixed Price contract is September 14, 2023. This SBIR contract opportunity was...
This is a $455,000 firm fixed price contract awarded by the National Cancer Institute (NCI), which is part of the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS). The contract was awarded to Mrimath LLC, a small disadvantaged, woman-owned limited liability company, for a Small Business Innovation Research (SBIR) Phase I project related to Artificial Intelligence-aided imaging for cancer prevention, diagnosis, and monitoring. The contract has a...
<p>This is a $994,198.78 cost-plus-fixed-fee definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Precision For Medicine (TX), Inc. on September 20, 2013. The contract is for research and development in biomedical (basic research) and has a period of performance through September 19, 2015. The contract is designated as a total small business set-aside.</p>